Related Experiment Video

Updated: May 20, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

Clearance of extracellular misfolded proteins in systemic amyloidosis: experience with transthyretin

Maria Rosário Almeida1, Maria João Saraiva

  • 1IBMC, Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal. ralmeida@ibmc.up.pt

FEBS Letters
|July 24, 2012
PubMed

Insights

Small molecules like doxycycline and EGCG can clear misfolded protein aggregates, offering hope for treating neurodegenerative diseases by targeting amyloid structures.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Misfolded protein accumulation (oligomers, fibrils) is central to neurodegenerative disorders.
  • These aggregates trigger toxic intracellular signaling pathways.
  • Amyloid structures are implicated in various systemic and localized amyloidoses.

Purpose of the Study:

  • To investigate the efficacy of small molecules in clearing protein aggregates.
  • To explore therapeutic strategies for neurodegenerative diseases by targeting amyloid structures.

Main Methods:

  • Utilized a transgenic mouse model for transthyretin (TTR) systemic amyloidosis.
  • Administered small compounds, including doxycycline and EGCG, to assess aggregate removal.
  • Investigated the role of extracellular chaperones (clusterin, metalloproteinases) in deposit clearance.

Main Results:

  • Doxycycline and EGCG demonstrated efficiency in removing protein aggregates in pre-clinical models.
  • These compounds show potential for clearing amyloidogenic structures.
  • Extracellular chaperones were identified as important players in the aggregate removal process.

Conclusions:

  • Small molecules can effectively disrupt and clear misfolded protein aggregates.
  • Targeting amyloid structures with compounds like doxycycline and EGCG is a promising therapeutic avenue for neurodegenerative diseases.
  • Understanding the role of extracellular chaperones is crucial for developing effective treatments.

More Related Videos

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging10:04

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...